This executive level summit explores strategies for innovation in the evolving world of data. Hear from a variety of stakeholder perspectives including industry, regulatory, CRO, and related organizations who will address the key strategies for success in the ever-changing post-marketing environment. The agenda features cutting-edge methods and in-depth case studies that provide pragmatic, real world takeaways. Attend this summit to gain critical insights and collaborate with your peers on the best methods and strategies for post-approval success.
http://www.worldcongress.com/events/PB14019/
BioPharma Medical Affairs Congress, West Coast WorldCongress
Medical Affairs teams face persistent challenges to be the interface between their company, product, KOL external experts, and prescribers. Evolving restrictions for compliance and limited commercial resources have placed greater emphasis onto Medical Affairs teams. BioPharma has greatly restricted resources and must rely greatly on these teams to communicate medical information and promote value. This summit focuses on strategies for engagement and success for medical affairs organizations to meet current and future organization needs.
This is a copy of my presentation from the 2012 AAM GIA Professional Development Conference in Palm Springs, California. The topic is marketing to referring physicians. Presenters: Dan Dunlop and Jill Lawlor.
The 3rd Physician Liaison Summit – Chicago provides real-life examples and strategies for liaisons to strengthen their programs, capture referrals, and increase hospital/health system revenue. This meeting provides proven methods and best practices from your local peers who are leaders in the field as they share insight and tips on how to adapt and implement these same methods into your hospital/health system. Conveniently located, this Midwest Summit is a must-attend meeting for all physician liaisons – whether new to the role, or in a leadership position with years of experience.
Discover how to use analytics to drive objectives and results.
Establish value both internally and in referrers' offices.
Prepare for the future of the liaison role.
http://www.worldcongress.com/events/HL14020/
10 Must Know Techniques for Managing Physician Relations in Today's Digital W...Endeavor Management
10 Must Know techniques for managing physician relations is Today’s digital world including 4 techniques to help you increase physician engagement, 3 ideas for enhancing strategic planning and 3 tips on demonstrating program effectiveness.
BioPharma Medical Affairs Congress, West Coast WorldCongress
Medical Affairs teams face persistent challenges to be the interface between their company, product, KOL external experts, and prescribers. Evolving restrictions for compliance and limited commercial resources have placed greater emphasis onto Medical Affairs teams. BioPharma has greatly restricted resources and must rely greatly on these teams to communicate medical information and promote value. This summit focuses on strategies for engagement and success for medical affairs organizations to meet current and future organization needs.
This is a copy of my presentation from the 2012 AAM GIA Professional Development Conference in Palm Springs, California. The topic is marketing to referring physicians. Presenters: Dan Dunlop and Jill Lawlor.
The 3rd Physician Liaison Summit – Chicago provides real-life examples and strategies for liaisons to strengthen their programs, capture referrals, and increase hospital/health system revenue. This meeting provides proven methods and best practices from your local peers who are leaders in the field as they share insight and tips on how to adapt and implement these same methods into your hospital/health system. Conveniently located, this Midwest Summit is a must-attend meeting for all physician liaisons – whether new to the role, or in a leadership position with years of experience.
Discover how to use analytics to drive objectives and results.
Establish value both internally and in referrers' offices.
Prepare for the future of the liaison role.
http://www.worldcongress.com/events/HL14020/
10 Must Know Techniques for Managing Physician Relations in Today's Digital W...Endeavor Management
10 Must Know techniques for managing physician relations is Today’s digital world including 4 techniques to help you increase physician engagement, 3 ideas for enhancing strategic planning and 3 tips on demonstrating program effectiveness.
What can healthcare executives learn from military decision-making, as it relates to predictiveanalytics in healthcare? As it turns out, quite a lot. Dale Sanders, senior vice president for strategy at Salt Lake City, Utah-based Health Catalyst, drew some surprising parallels between these two vital sectors of the economy during a concluding session at the Plante Moran Healthcare Executive Summit on June 5 in Chicago. His main theme was to remember that in predictive analytic analytics, it's the intervention that matters, noting that much of the industry is seduced by flashy predictive analytics "objects" without thinking through the needed interventions which are needed to get the proper ROI.
Are you looking to refresh your current workplace wellness program or have you thought about starting a workplace wellness program and don't know where to begin? Check out Workplace Wellness 2.0. In 60 minutes, you'll learn the 10 easy steps to create an inexpensive, community-based, volunteer-managed, thriving wellness initiative. Hope Health's managing editor, Jen Cronin, will walk you through the effective strategy based on the custom publisher's 30-plus years of working with hundreds of organizations and their workplace wellness efforts.
Learning Objectives:
How to begin a new program, or add new life to an existing wellness program, with the Workplace Wellness 2.0 concepts
How to take advantage of inexpensive, free and readily available resources to power your wellness program
How to create a program WITH employees vs. FOR employees.
About The Presenter
Jen Cronin
Managing Editor
Hope Health
An avid runner and foodie, Jen's goal is to help others embrace — and enjoy — a healthful lifestyle by creating inspiring, engaging, and fun content that focuses on simple ways people can take care of their mind, body, and spirit. Jen has more than 18 years of writing, editing, and communications project management experience. She has worked as a health reporter, a public relations specialist at a major medical school, and a marketing communications consultant for a Blue Cross Blue Shield affiliate before coming to HOPE Health in 2009.
What can healthcare executives learn from military decision-making, as it relates to predictiveanalytics in healthcare? As it turns out, quite a lot. Dale Sanders, senior vice president for strategy at Salt Lake City, Utah-based Health Catalyst, drew some surprising parallels between these two vital sectors of the economy during a concluding session at the Plante Moran Healthcare Executive Summit on June 5 in Chicago. His main theme was to remember that in predictive analytic analytics, it's the intervention that matters, noting that much of the industry is seduced by flashy predictive analytics "objects" without thinking through the needed interventions which are needed to get the proper ROI.
Are you looking to refresh your current workplace wellness program or have you thought about starting a workplace wellness program and don't know where to begin? Check out Workplace Wellness 2.0. In 60 minutes, you'll learn the 10 easy steps to create an inexpensive, community-based, volunteer-managed, thriving wellness initiative. Hope Health's managing editor, Jen Cronin, will walk you through the effective strategy based on the custom publisher's 30-plus years of working with hundreds of organizations and their workplace wellness efforts.
Learning Objectives:
How to begin a new program, or add new life to an existing wellness program, with the Workplace Wellness 2.0 concepts
How to take advantage of inexpensive, free and readily available resources to power your wellness program
How to create a program WITH employees vs. FOR employees.
About The Presenter
Jen Cronin
Managing Editor
Hope Health
An avid runner and foodie, Jen's goal is to help others embrace — and enjoy — a healthful lifestyle by creating inspiring, engaging, and fun content that focuses on simple ways people can take care of their mind, body, and spirit. Jen has more than 18 years of writing, editing, and communications project management experience. She has worked as a health reporter, a public relations specialist at a major medical school, and a marketing communications consultant for a Blue Cross Blue Shield affiliate before coming to HOPE Health in 2009.
The World Congress Summit - Leverage EHRs for Prescriber EngagementWorldCongress
This World Congress EHR Summit focuses on improving patient access by focusing on Health Information Technology and Health Information Management since the demand for Personal Health Management and Health Information Exchanges through ePrescribing and EHR portals has increased. Leverage Federal Quality Initiatives by supporting Meaningful Use through Electronic Health Records (EHRs)
Stage-gate Healthcare Initiatives • Strategise Innovative Models of Care • Assess Expense Management • Evaluate Partnerships in Managed Care • Measure Innovation • Improve Population Health
The 3rd Annual Global Pharmaceutical and Medical Meetings SummitWorldCongress
We are excited to announce the launch of the 3rd Annual Global Pharmaceutical and Medical Meetings Summit ™. The boutique-like Summit gathers senior pharmaceutical, biotech, medical device and healthcare meeting executives for empowering ROI-driven conversations about the industry’s biggest opportunities. Those conversations are amplified in a way no other event can be through ongoing networking and shared best practices.
As usual, World Congress commits to a 50/50 or better ratio of Meeting executive and Solution Providers.
Dr. Samuel Dyer will be moderating the 2nd Annual Medical Affairs Leaders Forum Asia in Hong Kong on August 5th-6th, 2014.
Dr. Samuel Dyer will also be speaking at the event and will represent the Medical Science Liaison Society.
This conference offers delegates an in-depth view of the latest initiatives that are simplifying and improving the clinical trial experience for the patient through data-sharing and setting industry standards. Leading individuals from biopharma partnerships and consortia come together to share the results and impact of their projects, as well as insights on areas ripe for future collaboration. The conference provides delegates with opportunities to learn from one another in regard to what works now and a forum to discuss how to leverage and build on collective experiences to advance innovation across the wider community.
We discuss:
Responsible Clinical Trials Data Sharing – Protecting Intellectual Property While Enabling Public Access to Data.
The Project Data Sphere Initiative – A New Data Sharing and Analytics Model for Cancer Research.
Clinical Trials Transformation Initiative – Advancing Central IRBs, IND Safety and a Quality by Design Approach to Clinical Trial Operations.
Lessons Learned from Pilot Studies on Risk-Based Monitoring Methodology to Identify Risk and Ensure Data Quality.
A Model to Create, Share, and Re-Use Structured Content throughout the Clinical Trial Life Cycle – The Sanofi-TransCelerate Collaboration.
CISCRP Recommendations – Communicate Trial Results to Participants to Improve Experience and Build Support for the Clinical Research Enterprise.
http://www.worldcongress.com/events/PB14014/
International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience
As new payment models emerge that emphasize value over volume, providers are being compelled to look more closely at how to motivate patients—especially those with multiple chronic conditions—to actively manage their care, make better decisions and change behaviors. This editorial webinar will explore the relationships between engagement and improved health outcomes, greater patient satisfaction and better resource utilization. Our panel of experts will share proven strategies for building patients' confidence, disseminating self-management tools and making the best use of your care team.
Real world data is no longer just for those trained in health economics and outcomes research — it can and will touch everyone in the pharma/healthcare space.
CBI asked industry's foremost RWD thought leaders a variety of questions to better understand how bio/pharmaceutical teams can collaborate and capture data in an aggregated form to continue to improve the value of products in development with real world, real-time data.
Real World Data - The New Currency in HealthcareJohn Reites
White paper published in June 2015 by CBI Life Sciences with interview insights from John Reites.
Real World Data (RWD) have become the bio/pharmaceutical industry’s treasure trove for information to inspire stakeholder decision-making. As an industry, professionals have increasingly been looking to RWD to not only assess the bene ts and risks of new medicines in clinical and real world settings, but also as a way to advise healthcare reimbursement decisions worldwide.
The New Orleans BioInnovation Center presents the annual Innovation Louisiana Conference on forming, funding, and growing a bioscience startup featuring national industry experts and investors. Through panel discussions and keynotes by national experts, the conference educates life science entrepreneurs, university researchers, students, and the business community on technology innovation issues. Get educated and inspired as you work to move breakthroughs from the lab to the market. Don’t miss this important opportunity to learn about key issues from finding funding for development and commercialization to successfully introducing innovations in a clinical setting.
Similar to Real World Evidence HEOR and Post Approval Studies Summit (20)
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement WorldCongress
Medication non-adherence is a $300 billion dollar national public health issue. Cross-industry stakeholders must address this system-wide challenge by sharing research, innovations, and strategies for improved outcomes. This summit is a must-attend event for executives interested in multi-disciplinary collaboration to drive adherence while offering innovative scalable patient engagement and adherence strategies. Leading industry payers, pharma, providers, pharmacists, patients, and technology providers convene to resolve the adherence issue and drive improved health outcomes.
Improve Adherence and Enhance Patient Engagement (Preview)WorldCongress
Medication non-adherence is a $300 billion dollar national public health issue. Cross-industry stakeholders must address this system-wide challenge by sharing research, innovations, and strategies for improved outcomes. This summit is a must-attend event for executives interested in multi-disciplinary collaboration to drive adherence while offering innovative scalable patient engagement and adherence strategies. Leading industry payers, pharma, providers, pharmacists, patients, and technology providers convene to resolve the adherence issue and drive improved health outcomes.
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
Contact center professionals face a number of challenges in the ever changing environment including management of intensifying cost pressures, maintenance and improvement of customer service, operation of globalized centers, and compliance with the changing regulatory environment. This summit explores innovative communication channels for customer engagement, technologies for cost effectiveness, and innovative strategies to stay at the front of the curve. Cross-industry perspectives provide a well-rounded and unique perspective on cutting edge technologies and strategies for contact center optimization.
http://www.worldcongress.com/events/PB14018/
Insurer's Customer Experience and Member Retention SummitWorldCongress
So you enrolled some of the 8 million health insurance consumers that were granted access to care under the Affordable Care Act and a number of other members during the inaugural AEP… Now what?
Topics include:
A focus on consumer experience as a differentiator in the market.
Shared sessions with providers surrounding member health, experience, and strategies to improve overall health outcomes through additive engagement programs for your members.
Strategies to retrain and revolutionize your call center operations to increase touch points with members, offer reform and policy advice, and include a sales aspect to persuade members to stay with your organization.
Advancements in technology that allow carriers to identify members at risk of cancelling their policies, and ways to personalize retention communications to prevent these cancelations.
Tips to navigate the rapidly changing post-reform landscape, and adapt to fluctuating legislation provisions and mandate extensions.
http://www.worldcongress.com/events/HW14084/
World Congress Patient Engagement SummitWorldCongress
Patient Engagement has long been a buzzword for clinicians and health care organizations — however true engagement strategies and patient-centered care designs have fallen flat for many organizations or become simply a theoretical vision. In order to meet Meaningful Use standards and most importantly improve clinical outcomes for patients, providers must actually engage and incorporate patients into the equation for better health outcomes.
Join us at the World Congress Patient Engagement Summit as we leave behind theory and bring about actionable change with actionable solutions to engage patients and move the needle on clinical outcomes and community health. Collaborate with multiple stakeholders and learn how some of the nation’s most innovation hospitals and health systems are engaging the most complex and vulnerable patient populations through communication strategies, community involvement, and technology.
http://www.worldcongress.com/events/HL14021/
The World Congress Summit on Patient Solution Services and Hub Design WorldCongress
Due to elevated needs for value-based and cost-effective treatments, bio/pharma has the opportunity to implement patient assistance and hub programs to support the patient journey. Assess strategies to ensure effective patient adherence, customer satisfaction, brand loyalty, and additional prescriber touch points by navigating reimbursement programs.
Understand ACA implications on opportunities and challenges of patient solution services.
Integrate support with nonprofit patient organizations and copay assistance foundations.
Break down regulatory barriers to successful patient engagement.
Benchmark metrics for successful Hubs: Optimize the right Hub design to fit portfolio needs.
Improve speed to therapy through new technologies.
http://www.worldcongress.com/events/PB14011/
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
The 2014 Health Insurance Exchanges Summit features a timely agenda focused on leveraging current “knowns” and progress to derive practical strategies for successful future participation in HIXs. Health plan executives, state and federal exchange officials, providers, and other policy experts convene to discuss business and operational considerations in a changing marketplace.
http://www.worldcongress.com/events/HL14022/
The 2014 Medicare Summit will feature a comprehensive, timely offering of sessions focused on key issues currently impacting the industry including the Dual Eligible population, ACOs, the sustainable growth rate, Medicare Advantage and star ratings. As the landscape of healthcare policy and reform continues to change at a rapid pace, it is imperative for hospitals, health systems, physicians, administrators, and health plans to stay well-informed so they can remain profitable.
http://www.worldcongress.com/events/HL14026/
Medicaid Expansion has ushered in new challenges for those working in the Medicaid Industry. At the 2014 Medicaid Summit, join Medicaid Directors and industry leaders to discuss solutions to the challenges that are surfacing with Medicaid Expansion. Be a part of the discussions on the Medicaid regulations and access to care and their impact on the Medicaid industry for state operators, providers and Medicaid health plans.
http://bit.ly/MedicaidSummit
THe Employee Well-Being Bootcamp for HR, Benefits and Wellness ProfessionalsWorldCongress
The conversation on employee wellness begins with the fundamentals. Through employer case studies and presentations by forward-thinking employers and industry thought leaders, this meeting delivers a fresh look at the evolution of wellness, innovative initiatives, and building programs founded on reconciling business goals with employee health accountability. Whether you are considering or are in the early stages of crafting the business plan for your employee well-being program, seeking training for new team members, or looking for a refresher, this meeting is ideal for your organization.
http://bit.ly/1p6GO2H
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Real World Evidence HEOR and Post Approval Studies Summit
1. Organized by:
to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
The World Congress Summit on
Emerging Strategies and Standards to Leverage Real World
Outcomes Data and Succeed Post-Marketing
August
11-12, 2014
Hyatt at the
Bellevue
Philadelphia, PA
real world evidence
heor and post approval
studies summit
S AVE U P TO $ 2 0 0 W H EN Y O U REGISTER B Y F RID AY, J U NE 2 0 , 2 0 1 4 !
f e a t u r e d s p e a k e r s :
Gregory W. Daniel, PhD, MPH, RPh
Managing Director, Engelberg Center for Health Care Reform
The Brookings Institution
Robert S. Epstein, MD, MS
Chief Executive Officer, Epstein Health
Former Chief Medical Officer and Chief R&D Officer
Medco
Usman Iqbal
Senior Medical Affairs Leader
AstraZeneca
Troy Sarich, PhD
Vice President, Real World Evidence
Janssen Scientific Affairs LLC
Janssen, a Johnson & Johnson Company
Josephine A. Sollano, Dr.PH
Vice President, Outcomes and Evidence
Global Health and Value
Pfizer
Robin S. Turpin, PhD
Director, US Health Care, Quality and
Outcomes, US Medical and Scientific Affairs
Takeda Pharmaceuticals USA, Inc.
Top Reasons to Attend:
• Collaborate with your colleagues on cutting-edge
strategies for leveraging real world data in
demonstrating outcomes
• Hear about the Sentinel Initiative as a
critical factor in the next steps for health care
• Understand how advocacy groups like PatientsLikeMe,
in collaboration with pharma, can produce better
outcomes for all stakeholders involved
• Gain critical insights on integrating data sources
to build networks for the future
• Hear from top executives from a variety of organizations
on how to meet the needs of payers, regulators, and
providers efficiently and cost-effectively
Address 3 Critical Factors in
Post-approval Success:
1. Innovative data strategies
and methodologies
2. Synchronize and integrate evidence
throughout product life cycle
3. Engage and develop
multi-stakeholder partnerships
for conference updates visit
www.worldcongress.com/RWD
Media Partners:
@wrldhealthcare
#WCRWD
2. to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.comto register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
Summit Objective:
This executive level summit explores strategies for innovation in the evolving
world of data. Hear from a variety of stakeholder perspectives including industry,
regulatory, CRO, and related organizations who will address the key strategies for
success in the ever-changing post-marketing environment. The agenda features
cutting-edge methods and in-depth case studies that provide pragmatic, real
world takeaways. Attend this summit to gain critical insights and collaborate with
your peers on the best methods and strategies for post-approval success.
Who Should Attend
Senior level leaders from:
• Health Economics
• Outcomes Research
• Real World Data/Evidence
• Phase IV/Late Phase
• Post-Approval/Post-Marketing
• Patient Registries
• Disease Registries
• Medical Affairs
• Clinical Affairs
• Clinical Operations
• Scientific Affairs
• Surveillance/Safety
• Regulatory Affairs
• Pharmacovigilance
• Risk Management
This conference will also benefit
Contract Research Organizations,
consultants, and solution providers
with expertise in post-approval studies,
real world data and outcomes
research, and big data vendors.
WH Y Y OU SHOULD SPONSOR
POSITION
your company
as a leading
solutions and
service provider
MEET
your market
SHOWCASE
new technology
innovations
INCREASE
brand awareness
GENERATE
leads and new
business
DEVELOP
new and
current client
relationships
MAXIMIZE YOUR NETWORKING OPPORTUNITIES
• Present to Key Players in Your Target Market
• Take Advantage of 1-on-1 Sponsor/Attendee Meetings Facilitated On-Site
CAPTURE A TRUE ROI Through Sponsorship of the Following:
Executive Tracks • Keynote Sessions • Networking Cocktail Reception Breakfast
Symposia • Market Insight Series • Luncheon
Executive Networking Participant and Networking Breaks
To inquire about Sponsorship and Executive Networking Opportunities,
Contact Suzanne Carroll, Business Development Manager, World Congress
Call 781-939-2648 or email Suzanne.Carroll@WorldCongress.com
The World Congress Summit on
Emerging Strategies and Standards to Leverage Real World Outcomes Data
and Succeed Post-Marketing
August
11-12, 2014
Hyatt at the
Bellevue
Philadelphia,
PA
real world
data strategies
3. DAY ONE – M o n day, Au g u st 1 1 , 2 0 1 4 • P r e-S u m m i t wo r k s h o p
8:00 am –
8:30 am
Workshop Registration and Morning Coffee
8:30 am –
11:45am P r e - S u m m i t W o r k s h o p
Managing for ‘Value’ in Health Care—A Global Executive Think Tank
Learn strategies from your peers and gain pragmatic takeaways on how to leverage pre-existing data sets. Understand how other nations capture data from a
variety of sources to create one comprehensive database. Engage in high level discussion to determine the most effective methods of data analysis, including:
• Head to head data, gaps from bench to bedside, real-world outcomes
• Eco system gaps — Global evidence/local decision-making, understand the global market, and how other countries are leveraging data sets
• Novel ways to earlier integrate the insights of providers, patients, and policy makers in drug development
Robert S. Epstein, MD, Chief Executive Officer, Epstein Health; Former Chief Medical Officer and Chief R&D Officer, Medco
Dr. Robert Epstein is a physician epidemiologist with an interest in bringing true innovation and hope to those in need of novel health care
solutions. He has worked for 30 years in the public and private health care sectors and most recently left a 15 year post as Chief Medical and
Chief R&D Officer for Medco, where he managed a global department of over 2000 researchers in 33 offices. He is currently CEO of Epstein
Health, a strategic consulting company. He is a frequent speaker at conferences in the US and abroad, and is often interviewed in the media.
Dr. Epstein has published more than 100 research papers in the peer-reviewed medical literature on a wide range of topics, and is currently
tracking and engaging with developers of hundreds of new technologies.
Tehseen Salimi, MD, MHA, Vice President, Global Medical Affairs, AstraZeneca
Dr. Tehseen Salimi is the Vice President in Global Medical Affairs at AstraZeneca, a multinational pharmaceutical company. She has over 20 years of
experience leading transformative patient-centric initiatives to bridge the evidence and value gaps. Her leadership developed in complex and rapidly
changing environments, is backed with strong tenure in managed care and global pharmaceutical arenas. Recently Dr. Salimi served in Global Medical
Affairs at Sanofi, where she developed a new Global Evidence and Value Development model to ensure ‘Evidence Continuum’ with real world evidence
definition, generation, and translation, starting early in development. Dr. Salimi developed Innovative Payer/HTA initiatives to support inclusion of
relative medical value in the development program and to demonstrate impact on Health Outcomes. She previously served in leadership positions at
several managed care organizations, including Cigna and Fallon Health Care. She is currently serving on both internal and external committees. Dr.
Salimi is a board member of the e-Health Initiative, CMTP, and chair of the Population Health Alliance International Committee. Exemplifying solid
commitment to her profession and determination to succeed, she has been highly respected by her colleagues for unwavering dedication and practical
knowledge. During her tenure, Dr. Salimi was honored with accolades, including the Physician’s Recognition Award for Best Outcomes and the
Superior Achievement Award at Cigna. She was also featured in the 1998 annual report of the National Committee for Quality Assurance (NCQA) for
the Best Practice Quality Improvement Initiative. She attributes her success to commitment, perseverance, and dedication to Innovation and learning.
Additional Thought Leaders TBA
11:45 am –
1:00 pm Lunch on Your Own/Main Summit Registration
DAY ONE – M o n day, Au g u st 1 1 , 2 0 1 4 • M a i n S u m m i t a g e n d a
1:00 pm –
1:15 pm Chairperson’s Welcome and Opening Remarks
Troy Sarich, PhD
Vice President, Real World Evidence, Janssen Scientific Affairs LLC
Janssen, a Johnson & Johnson Company
1:15 pm –
2:00 pm The Future of Regulations —
Understand the Sentinel Initiative and the Next Steps for the FDA
The FDA has a number of initiatives underway to improve the safety and efficacy of drugs and improve access to health care across the continuum.
Hear from Greg Daniel, Director of Evidence Development and Innovation at Brookings Institution, the convening group for the Sentinel Initiative, and
Reagan-Udall Foundation’s IMEDS program.
• Understand the Sentinel Initiative as a critical element in the future of health care, and the next steps for this project
• Discuss the role of the Reagan-Udall Foundation’s new IMEDS program as an avenue for pharma manufacturers to participate with sentinel data partners
• Prepare for regulatory changes in the next few years
• Discuss issues surrounding safety
Gregory W. Daniel, PhD, MPH, RPh
Managing Director, Evidence Development and Innovation, Engelberg Center for Health Care Reform
The Brookings Institution
to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.comto register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
Thereisa15minutecoffeeandnetworkingbreakfrom10:00am–10:15am
4. DAY ONE – M o n day, Au g u st 1 1 , 2 0 1 4 ( c o n t i n u e d )
2:00 pm –
2:45 pm Develop Better Treatment Pathways and Optimize Efficacy in
Comparative Effectiveness Research
• Discuss methodological challenges in Big Data analytics
• Optimize efficacy assessments in CER through competitive positioning and patient-centered outcomes
• Understand physician network analyses in Big Data to assess switching pathways and insights into prescribing patterns
• Analyze the application of CER in drug development and trial design optimization — Evidence continuum from effectiveness to efficacy
Usman Iqbal
Senior Medical Affairs Leader
AstraZeneca
2:45 pm –
3:30 pm Maximize Value of Registry Data for Improved Discovery and Innovation
• Develop a Collaborative Chronic Care Network for research and improvement
• Create a strong value proposition for improved patient enrollment and retention
• Data in Once — Re-purpose data for clinical care, improvement, and research
• Engage and sustain patient and family participation for optimum registry value
Richard Colletti, MD
Executive Network Director
ImproveCareNow
Sean Kennedy, MPH
Senior Director, Global Late Stage Operations
PPD, Inc.
3:30 pm –
4:00 pm
Networking and Refreshment Break
4:00 pm –
4:45 pm Case Study: Disease Registries — Real World Study Design
• Gain strategies for obtaining real world observational data within study budget — A balancing act
• Overcome challenges of real world disease registry protocol design
• Understand how data and outcomes are directly impacted by real world patients and their conditions
Todd Berner, MD
Director, Urology, Health Economics & Clinical Outcomes Research
Astellas Scientific and Medical Affairs, Inc
4:45 pm –
5:30 pm Create Interoperability Between Electronic Data Sources to Enhance Data for
Demonstrating Improved Outcomes
• Achieve meaningful communication between systems
• Address issues involving clinicians, customized EHR interfaces, and creating interoperability
• Gain insight to networks that are building health learning systems of the future
• Address socio-technical considerations in working with Big Data sets
Erin Holve, PhD, MPH, MPP
Senior Director
Academy Health
5:30 pm –
6:30 pm
Cocktail and Networking Reception
DA Y t w o – T u e s day, Au g u st 1 2 , 2 0 1 4
8:00 am –
8:30 am
Registration and Morning Coffee
8:30 am –
8:45 am
Chairperson’s Welcome and Review of Day One
Troy Sarich, PhD
Vice President, Real World Evidence, Janssen Scientific Affairs LLC
Janssen, a Johnson & Johnson Company
to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.comto register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
5. to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.comto register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
DA Y t w o – T u e s day, Au g u st 1 2 , 2 0 1 4 ( c o n t i n u e d )
8:45 am –
9:45 am
Balancing Data Expectations of Regulators and Payers for an Efficient Post-Marketing Strategy
• Advancement to the forefront in the regulatory space — Balancing benefits and risks and how that is translating into payer assessment of value
• Develop strategies for using sources of real world data in a way that aids both industry and payers
• Redefine cost effectiveness — Assessment of short term versus long terms costs, and meeting of the minds with payers
Kimberly McCleary
Director of Strategic Initiatives
FasterCures, A Center of the
Milken Institute
Michael Pollock
Vice President,
Real World Outcomes
PPD, Inc.
Josephine A. Sollano, Dr.PH
Vice President, Outcomes and Evidence
Global Health and Value
Pfizer
9:45 am –
10:30 am
The Intersection of Pharmaceutical Manufacturers and ACOs —
Leveraging Data for New Payment Models
• Forge new partnerships with ACOs and providers to mutually benefit all stakeholders
• Understand how data can be used to support performance tracking of drugs and devices for new payment models
• Evaluate outcomes-based contracting and other new uses for outcomes and economic data
Robin Turpin, PhD
Director, US Health Care, Quality and Outcomes, US Medical and Scientific Affairs
Takeda Pharmaceuticals USA Inc.
10:30 am –
11:00 am Networking and Refreshment Break
11:00 am –
11:45 am
Case Study: Patients Like Me — The Evolution of a Patient Powered Research Network
• Expand opportunities to share patient insights with the pharmaceutical industry through our Global Network Access
• Build models to integrate patient generated data with other health data to support improved health outcomes
• Collaborate with researchers and patients through the Open Research Exchange to develop patient-centered outcome measures suitable for use
across the drug development process
Sally Okun, MD, MMHS
Vice President, Advocacy, Policy, and Patient Safety
PatientsLikeMe
11:45 am –
12:30 pm
Data Linkages — How Real World Data can be Maximized to Support Development
and Post-Marketing Research Programs
• Understand the applications of real world data, and how it can be most effectively utilized
• Discuss how to implement rapid-cycle analysis for insight generation
• Discuss data mash ups and how to prepare for Big Data and advanced analytics
James Harnett, PharmD, MS
Senior Director Real World Data and Analytics
Pfizer
12:30 pm –
1:30 pm
Luncheon
1:30 pm –
2:15 pm
Enhance Large Scale Clinical Data Association Studies with Privacy Protections
• Learn how to de-identify large health data repositories in accordance with regulatory requirements
• Characterize how to tailor de-identification to different environments and organizational requirements
• Understand the types of investigations that can be accomplished with de-identified data and biomarkers
Bradley Malin, PhD
Associate Professor, Vice Chair of Biomedical Informatics in the School of Medicine
Vanderbilt University
2:15 pm –
3:00 pm
Prepare for the Future of Big Data — How to Create Richer Data Sources Now
• Understand the future of Big Data and its impact on the pharmaceutical industry
• Identify how to make data more applicable in day-to-day decision making
• Address ownership issues and how to work around business models
Sean McElligott
Associate Director, Customer Data and Analytics
Merck
3:00 pm Close of Summit
6. Registration Fee: Register By
6/20/2014
Register By
8/11/2014standard
Conference $ 2595.00 $ 2795.00
Conference Plus 1 Workshop $ 2895.00 $ 3095.00
pharma / biotech
Conference $ 1795.00 $ 1995.00
Conference Plus 1 Workshop $ 2095.00 $ 2295.00
Fee for conference includes welcome coffee, lunch, reception,
refreshments, and web-based conference documentation available pre-
and post-event, accessible through password-protected website. Checks in
U.S. funds drawn from U.S. bank payable to: WC Research Inc. No personal
checks accepted. Verification may be required for rate approvals.
SPECIAL TEAM DISCOUNTS: With so much great
content, you can’t possibly cover it alone. Sign up your
team and save. Find out more about special group
package discounts by calling 800-767-9499 or
emailing wcreg@worldcongress.com.
Participant Substitution and Cancellations:
Your registration may be transferred to a member of your organization
up to 24 hours in advance of the conference. Cancellations received
in writing on or before 30 days prior to the start of the event will be
refunded, less a $395 administrative charge. No refunds will be made
after this date; however, the registration fee less the $395 administrative
charge can be credited to another World Congress conference if you
register within 6 months from the date of this conference. In case of
conference cancellation, World Congress’ liability is limited to refund of
the conference registration fee only. World Congress reserves the right
to alter this program without prior notice.
Satisfaction guaranteed: World Congress stands behind the
quality of its conferences. If you are not satisfied with the quality of
the conference, a credit will be awarded towards a comparable World
Congress conference of your choice.
WEBSITE
WorldCongress.com/
RWD
Register Now!
E-MAIL
wcreg@worldcongress.com
Best Value
PRSRT STD
U.S. Postage
PAID
Gallery
World Congress
500 West Cummings Park, Suite 5200
Woburn, MA 01801
PB14010
Venue:
Hyatt at the Bellevue
200 South Broad Street
Philadelphia, PA 19102
888-421-1442
philadelphia.bellevue.hyatt.com
Room Rate: $199
Cut-off Date: 7/21/14
ATTN Mail Room: If undeliverable please forward to health outcomes/economics
S AVE U P TO $ 2 0 0 W H EN Y O U REGISTER B Y F RID AY, J U NE 2 0 , 2 0 1 4 !
The World Congress Summit on
Emerging Strategies and Standards to Leverage Real World Outcomes Data
and Succeed Post-Marketing
August
11-12, 2014
Hyatt at the
Bellevue
Philadelphia,
PA
real world
data strategies
Topics include:
• Develop better treatment pathways
and optimize efficacy in comparative
effectiveness research
• Maximize value of registry data for
improved discovery and innovation
• Balancing data expectations of
regulators, payers, and providers for an
efficient post-marketing strategy
• Data linkages — How real world data can
be maximized to support development and
post-marketing research programs
featured speakers:
James Harnett, PharmD, MS
Senior Director,
Real World Data
and Analytics
Pfizer
Sean McElligott
Associate Director,
Customer Data
and Analytics
Merck
Sally Okun, RN, MMHS
Vice President
of Advocacy, Policy
and Patient Safety
PatientsLikeMe
Tehseen Salimi, MD
Vice President,
Global Medical Affairs
AstraZeneca
to register, visit www.worldcongress.com/RWD | 800-767-9499 | wcreg@worldcongress.com
@wrldhealthcare
#WCRWD